Cytokinetics
CYTK
CYTK
126 hedge funds and large institutions have $311M invested in Cytokinetics in 2018 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
126
Holders Change
-1
Holders Change %
-0.79%
% of All Funds
2.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
42
Reduced
38
Closed
18
Calls
$591K
Puts
$731K
Net Calls
-$140K
Net Calls Change
-$13K
Top Buyers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$12M |
| 2 |
BlackRock
New York
|
+$5.7M |
| 3 |
Millennium Management
New York
|
+$2.98M |
| 4 |
SDIC
South Dakota Investment Council
Sioux Falls,
South Dakota
|
+$2.21M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$1.53M |
Top Sellers
| 1 |
Citigroup
New York
|
-$6.15M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.38M |
| 3 |
State Street
Boston,
Massachusetts
|
-$2.63M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.72M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.7M |
